COMBINATION THERAPY COMPRISING AN FGFR INHIBITOR AND A KRAS INHIBITOR

The present disclosure relates to methods of treating cancer by administering a compound, which is a Fibroblast Growth Factor Receptor (FGFR) inhibitor, in combination with a Kirsten rat sarcoma (KRAS) inhibitor. La presente descripción se refiere a métodos para tratar el cáncer mediante la administ...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FAVATA Margaret, HE Chunhong, ARJONA Alejandro Amador, YAO Wenqing, YE Qinda, WANG Xiaozhao, SUSICK Robert, CARLSEN Peter, QI Chao, SHVARTSBART Artem, LI Gencheng, SOKOLSKY Alexander, ZHU Wenyu, RIOS-DORIA Jonathan, MCCAMMANT Matthew, POLAM Padmaja, MIN Chang, GAN Pei, ZHAO Le, WANG Hui, HOANG Gia, HU Bin, ROACH Jeremy, POLICARPO Rocco, LAW Chunyin Marshall, ZHANG Fenglei, WEE Susan, ABDOLLAHI Angela, YANG Jeffrey C, YIN Haolin, LI Yong
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to methods of treating cancer by administering a compound, which is a Fibroblast Growth Factor Receptor (FGFR) inhibitor, in combination with a Kirsten rat sarcoma (KRAS) inhibitor. La presente descripción se refiere a métodos para tratar el cáncer mediante la administración de un compuesto, que es un inhibidor del receptor del factor de crecimiento de fibroblastos (FGFR), en combinación con un inhibidor del sarcoma de rata de Kirsten (KRAS).